Literature DB >> 1907997

Predominance of nonproductive rearrangements of VH81X gene segments evidences a dependence of B cell clonal maturation on the structure of nascent H chains.

D J Decker1, N E Boyle, N R Klinman.   

Abstract

Ig H chain V regions using the VH81X gene segment were PCR amplified from genomic DNA obtained from either splenic B cells or surface (s)Ig- bone marrow cells of BALB/c mice. Sequence analysis demonstrated that 93% of VH81X containing H chain V region genes in splenic B cells were rearranged nonproductively. Furthermore, 74% of rearrangements of VH81X among sIg- bone marrow cells were nonproductive. This contrasts with previous results obtained for rearrangements of members of the VH36-60 gene segment family among sIg- cells wherein, as a consequence of extensive clonal expansion after productive H chain V gene rearrangement, 80% of rearrangements were productive. The low proportion of productive rearrangements of VH81X is interpreted as indicating that most productive rearrangements of VH81X cannot facilitate clonal expansion, which would support the hypothesis that selection for clonal expansion and maturation is dependent on the amino acid sequence of nascent H chains. Additionally, because most productive rearrangements of VH81X cannot facilitate clonal maturation but do appear to mediate allelic exclusion, these processes are likely to be regulated independently.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1907997

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  14 in total

Review 1.  Relative roles of somatic and Darwinian evolution in shaping the antibody response.

Authors:  M Diaz; N R Klinman
Journal:  Immunol Res       Date:  2000       Impact factor: 2.829

Review 2.  Receptor selection in B and T lymphocytes.

Authors:  D Nemazee
Journal:  Annu Rev Immunol       Date:  2000       Impact factor: 28.527

Review 3.  Development of B cells producing natural autoantibodies to thymocytes and senescent erythrocytes.

Authors:  Richard R Hardy; Kyoko Hayakawa
Journal:  Springer Semin Immunopathol       Date:  2004-12-21

4.  New nucleotide sequence data on the EMBL File Server.

Authors: 
Journal:  Nucleic Acids Res       Date:  1991-12-11       Impact factor: 16.971

5.  Efficient generation of B lymphocytes by recognition of self-antigens.

Authors:  Cathrin Eschbach; Martina P Bach; Ingrid Fidler; Roberta Pelanda; Fabian Köhler; Klaus Rajewsky; Hassan Jumaa
Journal:  Eur J Immunol       Date:  2011-07-04       Impact factor: 5.532

6.  Selection of individual VH genes occurs at the pro-B to pre-B cell transition.

Authors:  Wenzhao Meng; Lenka Yunk; Li-San Wang; Avinash Maganty; Emily Xue; Philip L Cohen; Robert A Eisenberg; Martin G Weigert; Stephane J C Mancini; Eline T Luning Prak
Journal:  J Immunol       Date:  2011-07-11       Impact factor: 5.422

7.  The transition of pre-BI to pre-BII cells is dependent on the VH structure of the mu/surrogate L chain receptor.

Authors:  J Ye; S K McCray; S H Clarke
Journal:  EMBO J       Date:  1996-04-01       Impact factor: 11.598

8.  Immunoglobulin variable gene segment VH81X of the mouse is embedded in L1 transposon sequences.

Authors:  J Bachl; N Defranoux; M Wabl
Journal:  Immunogenetics       Date:  1995       Impact factor: 2.846

9.  Antibodies in a heavy chain knock-in mouse exhibit characteristics of early heavy chain rearrangement.

Authors:  Lenka Yunk; Wenzhao Meng; Philip L Cohen; Robert A Eisenberg; Eline T Luning Prak
Journal:  J Immunol       Date:  2009-07-01       Impact factor: 5.422

10.  CTCF-binding elements mediate control of V(D)J recombination.

Authors:  Chunguang Guo; Hye Suk Yoon; Andrew Franklin; Suvi Jain; Anja Ebert; Hwei-Ling Cheng; Erica Hansen; Orion Despo; Claudia Bossen; Christian Vettermann; Jamie G Bates; Nicholas Richards; Darienne Myers; Harin Patel; Michael Gallagher; Mark S Schlissel; Cornelis Murre; Meinrad Busslinger; Cosmas C Giallourakis; Frederick W Alt
Journal:  Nature       Date:  2011-09-11       Impact factor: 49.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.